IMBRUVICA 140 mg, 280 mg, 420 mg and 560 mg film-coated tablets *
Pharmacy Only: Prescription DHPC

  • Company:

    Janssen Sciences Ireland
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

  • COM (Click to Download)

    IMBRUVICA® (ibrutinib): New risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac events

    Direct Healthcare Professional Communication (DHPC)